Showing results (241-250 of 265) with videos related to

Sort By:
Pageof 27
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2009
Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppressionJosé A Mira, Alicia Gutiérrez-Valencia, Ignacio de los Santos Gil, et al.
AIDS (London, England)|June 15, 2012
Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patientsJosé A Mira, Antonio Rivero, Ignacio de Los Santos-Gil, et al.
HIV Clinical Trials|June 11, 2017
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort studyKarin Neukam, Luis E Morano-Amado, Antonio Rivero-Juárez, et al.
Antiviral Therapy|February 5, 2008
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patientsJosé A Mira, Luis F López-Cortés, Dolores Merino, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 7, 2015
Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south SpainA Rivero-Juarez, A Gutierrez-Valencia, M Castaño, et al.
The Journal of Hospital Infection|December 19, 2024
Gel nail polish does not have a negative impact on the nail bacterial burden nor on the quality of hand hygiene with an alcohol-based hand rubP Arreba, J Iglesias, J Ríos, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2007
Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patientsJuan A Pineda, José A Mira, Ignacio de los Santos Gil, et al.
Current HIV Research|January 3, 2014
Protective effect of CCR5 Delta-32 allele against HIV-1 in Mexican womenJesús A Estrada-Aguirre, Silvestre G Cázarez-Salazar, Luis A Ochoa-Ramírez, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 28, 2015
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopeniaJ A Mira, K Neukam, L F López-Cortés, et al.
Child Psychiatry and Human Development|January 23, 2026
Intergenerational Effects of the Mother's History of Neglect and Parental Bonding on Her Postpartum Bonding: A Pilot StudyJahleel D Torres-Pérez, Isel J Figueroa-Marcano, Veronique I Rosado-Abreu, et al.
Pageof 27